Global pharmaceutical packaging market 2016–2020 — market segmentation by product type, material type & packaging type
![](/46/pdcnewsitem/03/86/52/research%20and%20markets.jpg)
Research and Markets has announced the addition of the "Global Pharmaceutical Packaging Market 2016–2020" report to their offering.
The report predicts the global pharmaceutical packaging market to grow at a CAGR of around 6% during the forecast period.
A major trend is the rise in demand for ampules and vials. These containers are popular owing to the high bioavailability and fast action rates of the drug, and the drug is administered in the injectable form. In addition, trends that will keep on pushing the market are integration with protective technologies, popularity of superior plastics as a raw material, and growth in contract manufacturing will further fuel the growth of the market
.According to the report, increased adoption of prefillable syringes is a major driver, which is expected to propel the growth of the market during the forecast period. These syringes are gaining popularity because of the rise in chronic diseases where patients need to self-administer drugs multiple times in a week. This is fueling innovations in syringes such as multi-chambered syringes and technology to minimize leachables and extractables, thus driving the growth of global market.
Further, the report states that one of the key challenges is the fragmentation of the market. Most of the players operating in the market are micro, small, and medium-sized enterprises (MSMEs). The business models of large corporations are different from the business models of these small companies.
Plastic pharmaceutical packaging accounted for a market share of around 61% during 2015. Plastic is the most preferred packaging material as it is available in a variety of grades, has significant barrier properties, is chemically inert, and can be used to create attractive packages with esthetic appeal, which helps in the marketing and promotional activities for the drug. The grades of plastic used for packaging include PE, PP, polyolefin, PET, and PVC.
North America dominated the market during 2015, accounting for a market share of around 35%. The pharmaceutical packaging market in North America is dominated by the US, which is a highly competitive market.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance